These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 5119316)

  • 1. Non-protein-bound hydroxyproline in plasma in renal bone disease.
    Bishop MC; Smith R
    Clin Chim Acta; 1971 Jul; 33(2):403-8. PubMed ID: 5119316
    [No Abstract]   [Full Text] [Related]  

  • 2. Recognition of osteodystrophy in chronic uremia.
    Kaye M
    Am J Med Sci; 1971 Apr; 261(4):182-7. PubMed ID: 4931264
    [No Abstract]   [Full Text] [Related]  

  • 3. The possible role of calcitonin deficiency in the development of bone disease due to chronic renal failure.
    Kanis JA; Earnshaw M; Heynen G; Russell RG; Woods CG
    Calcif Tissue Res; 1977 May; 22 Suppl():147-53. PubMed ID: 912516
    [No Abstract]   [Full Text] [Related]  

  • 4. The hydroxyproline content of plasma of patients with impaired renal function.
    Hart W; Duursma SA; Visser WJ; Njio LK
    Clin Nephrol; 1975; 4(3):104-8. PubMed ID: 1183097
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasma hydroxyproline in uremia: relationships with histologic and biological indices of bone turnover.
    Cundy T; Bartlett M; Bishop M; Earnshaw M; Smith R; Kanis JA
    Metab Bone Dis Relat Res; 1983; 4(5):297-303. PubMed ID: 6621355
    [No Abstract]   [Full Text] [Related]  

  • 6. Effects of haemodialysis on bone in chronic renal failure.
    Bishop MC; Woods CG; Oliver DO; Ledingham JG; Smith R; Tibbutt DA
    Br Med J; 1972 Sep; 3(5828):664-7. PubMed ID: 4650845
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Plasma hydroxyproline in chronic renal failure (author's transl)].
    Heidbreder E; Lüke F; Heidland A
    Med Klin; 1976 Nov; 71(45):1945-51. PubMed ID: 995035
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of parathyroid hormone on bone resorption in uremic patients.
    Arata RO; Campos C; Mautalen CA
    Medicina (B Aires); 1976; 36(2):113-20. PubMed ID: 933833
    [No Abstract]   [Full Text] [Related]  

  • 9. Letter: Serum-alkaline-phosphatase during maintenance haemodialysis.
    Stepán J; Pilarova T
    Lancet; 1975 May; 1(7917):1188-9. PubMed ID: 48800
    [No Abstract]   [Full Text] [Related]  

  • 10. Letter: Plasma biochemistry in haemodialysed patients.
    Bishop MC
    Lancet; 1973 Dec; 2(7841):1328-9. PubMed ID: 4127674
    [No Abstract]   [Full Text] [Related]  

  • 11. [Urinary hydroxyproline correlated with quantitative bone histological data. Attempted physiopathological interpretation].
    Lejeune E; Meunier P; Ruitton P; Orgiazzi J
    Rev Rhum Mal Osteoartic; 1972 Feb; 39(2):107-13. PubMed ID: 4343436
    [No Abstract]   [Full Text] [Related]  

  • 12. [Thermoliability of alkaline phosphatase in patients on hemodialysis].
    Botey A; Matamoros N; Revert L
    Rev Clin Esp; 1975 Jul; 138(2):155-62. PubMed ID: 1178961
    [No Abstract]   [Full Text] [Related]  

  • 13. Variations of parathyroid hormone and bone biomarkers are concordant only after a long term follow-up in hemodialyzed patients.
    Delanaye P; Warling X; Moonen M; Smelten N; Jouret F; Krzesinski JM; Maillard N; Pottel H; Cavalier E
    Sci Rep; 2017 Oct; 7(1):12623. PubMed ID: 28974744
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 1,25-dihydroxycholecalciferol in patients with chronic renal failure.
    Henderson RG; Ledingham JG; Norman AW; Oliver DO; Preston C; Russell RG; Small DG; Smith R; Warner GT; Woods CG
    Proc Eur Dial Transplant Assoc; 1973; 10(0):202-9. PubMed ID: 4802654
    [No Abstract]   [Full Text] [Related]  

  • 15. Hypocalcaemia and bone disease in renal failure.
    Cochran M; Bulusu L; Horsman A; Stasiak L; Nordin BE
    Nephron; 1973; 10(2):113-40. PubMed ID: 4710977
    [No Abstract]   [Full Text] [Related]  

  • 16. Reevaluation of the usefulness of serum free hydroxyproline as a parameter for assessing renal osteodystrophy.
    Uehara H
    Nihon Jinzo Gakkai Shi; 1993 Jan; 35(1):49-58. PubMed ID: 8336400
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Symptomatic skeletal disease in non-terminal renal failure.
    Ingham JP; Kleerekoper M; Stewart JH; Posen S
    Med J Aust; 1974 Jun; 1(22):873-6. PubMed ID: 4546933
    [No Abstract]   [Full Text] [Related]  

  • 18. [Osteopathy in chronic kidney failure].
    Binswanger U; Fischer J; Schenk R; Merz W
    Dtsch Med Wochenschr; 1971 Dec; 96(49):1914-5 passim. PubMed ID: 5127025
    [No Abstract]   [Full Text] [Related]  

  • 19. Osteopathy in maintenance hemodialysis.
    Krempien B; Ritz E; Beck U; Keilbach H
    Virchows Arch A Pathol Pathol Anat; 1972; 357(4):257-74. PubMed ID: 4629286
    [No Abstract]   [Full Text] [Related]  

  • 20. Dihydrotachysterol (DHT) and supplemental calcium therapy in dialysis patients.
    Kliger AS; Yap P; Jensen P; Finkelstein FO
    Proc Clin Dial Transplant Forum; 1976 Nov 19-22; 6():184-90. PubMed ID: 1029884
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.